| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2174/1568011054222337 |
| P698 | PubMed publication ID | 16101492 |
| P50 | author | Yves Pommier | Q28320644 |
| P2093 | author name string | Christophe Marchand | |
| P433 | issue | 4 | |
| P304 | page(s) | 421-429 | |
| P577 | publication date | 2005-07-01 | |
| P1433 | published in | Anti-Cancer Agents in Medicinal Chemistry | Q15759240 |
| P1476 | title | Interfacial inhibitors of protein-nucleic acid interactions | |
| P478 | volume | 5 |
| Q24627296 | (-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases |
| Q33584683 | A general method for discovering inhibitors of protein-DNA interactions using photonic crystal biosensors |
| Q33812633 | A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex |
| Q91903448 | Carboxylate-functionalized foldamer inhibitors of HIV-1 integrase and Topoisomerase 1: artificial analogues of DNA mimic proteins |
| Q33947475 | Cleavage of plasmid DNA by eukaryotic topoisomerase II. |
| Q35030777 | Contributions of the D-Ring to the activity of etoposide against human topoisomerase IIα: potential interactions with DNA in the ternary enzyme--drug--DNA complex. |
| Q42583194 | Coordinating the two protomer active sites of human topoisomerase IIalpha: nicks as topoisomerase II poisons |
| Q29400901 | DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition |
| Q39886827 | DNA binding ellipticine analogues: synthesis, biological evaluation, and structure-activity relationships. |
| Q36903197 | DNA topoisomerase II, genotoxicity, and cancer |
| Q39320242 | DNA topoisomerase-targeting chemotherapeutics: what's new? |
| Q28284744 | DNA topoisomerases and their poisoning by anticancer and antibacterial drugs |
| Q24642324 | Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement |
| Q35682250 | Drug interactions with Bacillus anthracis topoisomerase IV: biochemical basis for quinolone action and resistance |
| Q27000099 | Drugging topoisomerases: lessons and challenges |
| Q38310166 | Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: role of DNA backbone flexibility and an open catalytic site |
| Q39939254 | Etoposide quinone is a covalent poison of human topoisomerase IIβ. |
| Q33536938 | Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective |
| Q33814351 | HIV-1 IN inhibitors: 2010 update and perspectives |
| Q37034614 | HIV-1 integrase inhibitors: update and perspectives |
| Q36859298 | Human topoisomerase IIalpha uses a two-metal-ion mechanism for DNA cleavage |
| Q34909651 | Interactions between the etoposide derivative F14512 and human type II topoisomerases: implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage |
| Q38559481 | Interfacial inhibitors |
| Q37968897 | Interfacial inhibitors: targeting macromolecular complexes |
| Q33645817 | Mapping the ribosomal protein S7 regulatory binding site on mRNA of the E. coli streptomycin operon |
| Q33814406 | Mechanisms and inhibition of HIV integration |
| Q39293345 | Mechanisms of DNA damage, repair, and mutagenesis |
| Q24311803 | Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1 |
| Q30354195 | Optimizing scoring function of protein-nucleic acid interactions with both affinity and specificity. |
| Q34245624 | Physical Trapping of HIV-1 Synaptic Complex by Different Structural Classes of Integrase Strand Transfer Inhibitors |
| Q37658182 | Phytochemicals as Anticancer and Chemopreventive Topoisomerase II Poisons |
| Q33957966 | Quinone-induced enhancement of DNA cleavage by human topoisomerase IIalpha: adduction of cysteine residues 392 and 405. |
| Q36557533 | Repair of topoisomerase I-mediated DNA damage |
| Q37108461 | The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing |
| Q36839637 | The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs |
| Q29614976 | Topoisomerase I inhibitors: camptothecins and beyond |
| Q37652882 | Topoisomerase II and leukemia |
| Q38968355 | Topoisomerases: Resistance versus Sensitivity, How Far We Can Go? |
| Q37323539 | Using 3'-bridging phosphorothiolates to isolate the forward DNA cleavage reaction of human topoisomerase IIalpha |
Search more.